Pathogenesis-directed therapy of methylphenidate-induced oxidative heart damage in rats.

AIM

The current study aimed to investigate the protective effects of adenosine triphosphate (ATP), metyrosine, and melatonin on possible methylphenidate cardiotoxicity in rats using biochemical and histopathological methods.

METHODS

Thirty rats were separated into five groups: healthy (HG), methylphenidate (MP), ATP + methylphenidate (ATMP), metyrosine + methylphenidate (MSMP), and melatonin + methylphenidate (MLMP). ATP (5 mg/kg) was given intraperitoneally once daily, metyrosine (50 mg/kg) orally twice daily, and melatonin (10 mg/kg) orally once daily. Methylphenidate (10 mg/kg) was administered orally once daily for 1 h after ATP, metyrosine and melatonin. The protocol was repeated for 30 days. Subsequently, blood samples were taken from the tail veins of the animals to measure adrenaline, noradrenaline, dopamine, troponin I (TP I) and creatine kinase MB (CK-MB) levels; the animals were then euthanized and the heart tissues were extracted. Tissues were analyzed for malondialdehyde (MDA), total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) and histopathologically.

RESULTS

In MP group, MDA, adrenaline, noradrenaline, dopamine, TP I, and CK-MB levels increased ( < 0.001) and tGSH, SOD, and CAT levels decreased ( < 0.001) compared to HG, and histopathologic damage developed. Oxidant levels were lower and antioxidant levels were higher in ATMP, MSMP, and MLMP groups compared to MP group ( < 0.001). Catecholamine levels were measured lower in the MSMP group compared to the MP group ( < 0.001). TP I and CK-MB levels were lower in ATMP, MSMP and MLMP groups compared to MP ( < 0.05), with the lowest being in rats given ATP ( < 0.001). ATP, melatonin, and metirozin applications were effective to different degrees in preventing histopathological changes.

CONCLUSION

This study may guide clinical trials using ATP and melatonin to prevent methylphenidate-induced myocardial injury.